Abstract Submission Opens
April 1, 2021
Abstract Submission Deadline
May 15, 2021 (5:00 PM EST)
Rolling Acceptance for Abstracts
June 2, 2021 for Oral Presentations
Late Breaker Submission:
Opens May 24, 2021
Late Breaker Submission Deadline
May 28, 2021 (5:00 PM EST)
Notification: June 2, 2021
Final Poster and Abstract for Virtual Posting Must be provided to RAD no later than June 4, 2021 at 12 noon (EST)
Please be aware of the following dates and requirements in the event you have been selected:
Is there an abstract submission fee?
Yes - US $50.00
Are there rules about previous presentation of data?
Encore presentations are permitted. All abstracts will undergo review by the Abstract Review Committee who will assess for scientific merit and novelty.
Is a trial-in-progress abstract allowed?
Is there an author limit for abstracts?
Is there a word limit or character count to which we should adhere?
May we include figures and tables in the abstract?
May a non-author present on behalf of the authors?
Yes, only if:
• Presenter is not a company employee within the pharma industry
• Presenter is a colleague attending the conference and presenting on behalf of authors who cannot attend
Is Industry Sponsorship allowed?
Is Society Sponsorship required for admission?
Are QR codes allowed on the posters?
Do you have any policy regarding the usage of brand names or trademarks in abstracts or posters?
Brand names or trademarks are not allowed - only generic names may be used.
Will you accept an abstract presenting only the study design?
It would be preferable if the abstract included the results/read outs; however, if they are not available at the time of submission but will be presented at the conference, that would be acceptable.
What are the Embargo Rules, if any?
• None for encores.
• For primary disclosures, scientific dissemination should be reserved until after the Conference. Press releases and media coverage are allowed in advance of the Conference.
Where will the abstracts be published?
All accepted abstracts will be published in the British Journal of Dermatology Q4/2021 as well as on the RAD Website
What is the Abstract Notification Date?
Within approximately 1 week of abstract submission
What is the pre-Conference abstract availability date/access venue?
Saturday, June 12, 2021 - 5:00 PM EST
What is the post-Conference abstract availability date/access venue?
Is there a language requirement for the abstracts?